<DOC>
	<DOCNO>NCT02460705</DOCNO>
	<brief_summary>Currently enrol patient Ulcerative Colitis . Enrollment experimental treatment patient Crohn 's Disease stop safety evaluation . This prospective , open label pilot study patient symptoms Inflammatory bowel disease receive FMT therapy deliver via colonoscopy . The investigator hypothesize FMT safe effective treatment patient inflammatory bowel disease . The aim : 1 . To determine symptom inflammatory bowel disease successfully treat Fecal Microbial Transplantation . 2 . To determine endoscopic appearance colon ileum improve follow treatment Fecal Microbial Transplantation .</brief_summary>
	<brief_title>Fecal Microbiota Transplant Inflammatory Bowel Disease</brief_title>
	<detailed_description>Currently enrol patient Ulcerative Colitis . Enrollment experimental treatment patient Crohn 's Disease stop safety evaluation . This prospective , open label pilot study patient symptoms acute chronic inflammatory bowel disease receive FMT therapy deliver via colonoscopy . Number Subjects : This study aim enroll approximately 60 patient inflammatory bowel disease . All patient IBD evaluate UCSF Center Inflammatory Bowel Disease . Patients eligible study identify regularly schedule clinic visit . Patients express interest set meet clinical research coordinator go study detail obtain informed consent . Prior FMT procedure stool sample check ova parasite , C. difficile toxin fecal calprotectin . Serum test include erythrocyte sedimentation rate ( ESR ) , C-reactive protein ( CRP ) , Anti-nuclear antibody ( ANA ) , complete blood cell count , HIV , screen Hepatitis A , B , C ( hep A IgM , hep B surface antigen antibody , Hep C antibody ) , creatinine . 8 day treatment , patient take 5 day course rifaximin discontinue 3 day FMT treatment . Patients IBD undergo colonoscopy , consider part standard care patient ongoing inflammation consider study procedure . The colonoscopy do endoscopic unit Mt . Zion , Parnassus and/or Mission Bay . During procedure fecal transplant take place . For FMT , 250 cc FMT material ( previously screen stool OpenBiome ) administer via endoscope . The scope withdrawn patient recover endoscopy unit per protocol . Patients undergone FMT IBD call next day ensure adverse event occur . Patients scheduled second FMT treatment follow clinic visit 4 week inital FMT procedure . Patients contact phone 24 hour , 1 week , 1 month every 3 month 3 year FMT treatment . A 6 month colonoscopy do check mucosal heal . During FMT procedure 6 month colonoscopy total 6 ileum rectosigmoid biopsy obtain . In addition investigator collect research blood sample initial procedure , 1 6 month initial FMT treatment . One week second FMT treatment , patient give option enroll 6 week , per week FMT capsule therapy administer 1 hour clinic visit . Patients receive capsule call follow ensure adverse event occur . Study participant ask submit stool sample prior treatment , one month treatment every 3 month treatment 1 year duration total 6 sample . Study participant also administer patient survey assess clinical outcomes/symptoms prior treatment 1 month receive treatment . In addition , patient receive phone call 24 hour , 1 week , 1 month every 3 month 3 year FMT treatment .</detailed_description>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Patients history Ulcerative Colitis confirm endoscopy pathology Mayo clinic ulcerative colitits disease activity score 6 great . Concurrent therapy mesalamine , immunomodulators , corticosteroid biologic agent allow continue study . Female patient pregnant . Patients severe immunosuppression ( absolute neutrophil count &lt; 1000 CD4 count &lt; 200 ) . Patients untreated enteric infection . Patients colon cancer dysplasia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>